Commercial Synthesis of Azilsartan Kamedoxomil: An Angiotensin II Receptor Blocker

Srinivas Garaga,Nimesh C. Misra,Ambati V. Raghava Reddy,Koilpillai Joseph Prabahar,Chandiran Takshinamoorthy,Paul Douglas Sanasi,Korupolu Raghu Babu
DOI: https://doi.org/10.1021/op500357r
2015-03-23
Abstract:A commercially viable process for the preparation of azilsartan kamedoxomil, an angiotensin II receptor blocker, has been developed. The present work describes the novel synthesis of azilsartan medoxomil from amidoxime methyl ester. The present work also describes the improved synthesis of amidoxime methyl ester and azilsartan kamedoxomil. This process features a high overall yield (36%) with 99.52% HPLC purity.
chemistry, organic, applied
What problem does this paper attempt to address?